205 related articles for article (PubMed ID: 36552885)
1. An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation.
Mobashir M; Turunen SP; Izhari MA; Ashankyty IM; Helleday T; Lehti K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552885
[TBL] [Abstract][Full Text] [Related]
2. Network analysis of an in vitro model of androgen-resistance in prostate cancer.
Detchokul S; Elangovan A; Crampin EJ; Davis MJ; Frauman AG
BMC Cancer; 2015 Nov; 15():883. PubMed ID: 26553226
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
4. Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer.
Khouja HI; Ashankyty IM; Bajrai LH; Kumar PKP; Kamal MA; Firoz A; Mobashir M
Sci Rep; 2022 May; 12(1):7240. PubMed ID: 35508649
[TBL] [Abstract][Full Text] [Related]
5. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
[TBL] [Abstract][Full Text] [Related]
6. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
Li HY; Jin N; Han YP; Jin XF
Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
[TBL] [Abstract][Full Text] [Related]
7. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
[TBL] [Abstract][Full Text] [Related]
8. Insight into the potential candidate genes and signaling pathways involved in lymphoma disease in dogs using a comprehensive whole blood transcriptome analysis.
Sheet S; Oh YI; Arora D; Choi BH; Ko M; Nam Y; Lim Y; Lim JA; Park M; Park W; Seo KW; Lee KT
Gene; 2022 Sep; 838():146735. PubMed ID: 35835403
[TBL] [Abstract][Full Text] [Related]
9. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
10. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
11. Integrative Network Analysis of Differentially Methylated and Expressed Genes for Biomarker Identification in Leukemia.
Sanchez R; Mackenzie SA
Sci Rep; 2020 Feb; 10(1):2123. PubMed ID: 32034170
[TBL] [Abstract][Full Text] [Related]
12. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
14. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
15. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
16. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
17. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
18. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
19. Screening of candidate genes associated with high titer production of oncolytic measles virus based on systems biology approach.
Rastegarpanah M; Azadmanesh K; Negahdari B; Asgari Y; Mazloomi M
Virus Genes; 2022 Aug; 58(4):270-283. PubMed ID: 35477822
[TBL] [Abstract][Full Text] [Related]
20. Identification of key genes and pathways in benign prostatic hyperplasia.
Ke ZB; Cai H; Wu YP; Lin YZ; Li XD; Huang JB; Sun XL; Zheng QS; Xue XY; Wei Y; Xu N
J Cell Physiol; 2019 Nov; 234(11):19942-19950. PubMed ID: 31187492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]